Savannah River Site Dose Reconstruction Project, 51624 [E6-14424]
Download as PDF
<![CDATA[
51624
Federal Register / Vol. 71, No. 168 / Wednesday, August 30, 2006 / Notices
Atlanta, GA 30333, Telephone
404.639.2543.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: August 21, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–14418 Filed 8–29–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Savannah River Site Dose
Reconstruction Project
The Centers for Disease Control
and Prevention (CDC) and the Agency
for Toxic Substances and Disease
Registry (ATSDR).
ACTION: CDC and ATSDR announce the
following meeting.
jlentini on PROD1PC65 with NOTICES
AGENCY:
Name: Public Meeting to Present
Final Report of the Savannah River Site
Dose Reconstruction Project.
Time and Date: 6 p.m.–8 p.m.,
(Eastern Time), Tuesday, September 19,
2006.
Place: University of South Carolina/
Aiken, Conference Center/Business and
Education Building, Room 122, 471
University Parkway, Parking Lot ‘‘C’’,
Aiken, South Carolina 29801.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 50
people.
Background: Under a Memorandum
of Understanding (MOU) signed in
December 1990 with DOE, and replaced
by MOUs signed in 1996 and 2000, the
Department of Health and Human
Services (HHS) was given the
responsibility and resources for
conducting analytic epidemiologic
investigations of residents of
communities in the vicinity of DOE
facilities, workers at DOE facilities, and
other persons potentially exposed to
radiation or to potential hazards from
non-nuclear energy production use.
HHS delegated program responsibility
to CDC.
In addition, a memo was signed in
October 1990 and renewed in November
1992, 1996, and in 2000, between
VerDate Aug<31>2005
16:39 Aug 29, 2006
Jkt 208001
ATSDR and DOE. The MOU delineates
the responsibilities and procedures for
ATSDR’s public health activities at DOE
sites required under sections 104, 105,
107, and 120 of the Comprehensive
Environmental Response,
Compensation, and Liability Act
(CERCLA or ‘‘Superfund’’). These
activities include health consultations
and public health assessments at DOE
sites listed on, or proposed for, the
Superfund National Priorities List and
at sites that are the subject of petitions
from the public; and other healthrelated activities such as epidemiologic
studies, health surveillance, exposure
and disease registries, health education,
substance-specific applied research,
emergency response, and preparation of
toxicological profiles.
Purpose: CDC will present the Final
Report of the Savannah River Site Dose
Reconstruction Project to area
stakeholders and provide a forum for
community interaction. This meeting
will also serve as a vehicle for members
of the public to express concerns to
CDC.
Matters To Be Discussed: The
National Center for Environmental
Health (NCEH) will make a presentation
of the Final Report of the Savannah
River Site Dose Reconstruction Project.
There will be time for public questions
and comments. Agenda items are
subject to change as priorities dictate.
Contact Person For Additional
Information: Phillip R. Green, Public
Health Advisor, Radiation Studies
Branch, Division of Environmental
Hazards and Health Effects, NCEH, CDC,
1600 Clifton Road, NE., (MS–E39),
Atlanta, GA 30333, telephone 404/498–
1717, fax 404/498–1811, or e-mail
address: prg1@cdc.gov
Dated: August 23, 2006.
James D. Seligman,
Chief Information Officer, Centers for Disease
Control and Prevention (CDC).
[FR Doc. E6–14424 Filed 8–29–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Prospective Grant of Exclusive
License: Prophylactic Use of
Pneumococcal Surface Adhesin A
Protein as a Vaccine
Office of Technology Transfer;
Centers for Disease Control and
Prevention (CDC); Department of Health
and Human Services.
AGENCY:
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
ACTION:
Notice.
SUMMARY: This is a notice in accordance
with 35 U.S.C. 209(e) and 37 CFR
404.7(a)(1)(i) that the Centers for Disease
Control and Prevention (CDC),
Technology Transfer Office, Department
of Health and Human Services (DHHS),
is contemplating the grant of a
worldwide, limited field of use,
exclusive license to practice the
inventions embodied in the patent and
patent applications referred to below to
Intercell, having a place of business in
Vienna, Austria. The patent rights in
these inventions have been assigned to
the government of the United States of
America. The patent and patent
applications to the licensed are: U.S.
Patent No. 5,422,427 entitled
‘‘Pneumococcal Fimbrial Protein A,’’
issued 06.06.95.
U.S. Patent No. 6,312,944 entitled
‘‘Pneumococcal Fimbrial Protein A,’’
issued 11.06.01.
U.S. Patent No. 5,854,416 entitled
‘‘Streptococcus pneumoniae 37-kDa
Surface Adhesin A Protein and
Nucleic Acids Coding Therefore,’’
issued 12.29.98 (CDC Ref: E–157–91/
4).
U.S. Patent No. 6,217,884 entitled
‘‘Streptococcus pneumoniae 37-kDa
Surface Adhesin A Protein,’’ issued
04.17.01.
U.S. Patent No. 6,773,880 entitled
‘‘Streptococcus pneumoniae 37-kDa
Surface Adhesin A Protein,’’ issued
06.05.03.
The prospective exclusive license will
be royalty-bearing and will comply with
the terms and conditions of 35 U.S.C.
209 and 37 CFR 404.7.
ADDRESSES: Requests for a copy of these
patent applications, inquiries,
comments, and other materials relating
to the contemplated license should be
directed to Thomas E. O’Toole, MPH,
Chief Licensing Officer, Technology
Transfer Office, Centers for Disease
Control and Prevention (CDC), 4770
Buford Highway, Mailstop K–79,
Atlanta, GA 30341, telephone: (770)
488–8600; facsimile: (770) 488–8615.
Applications for a license filed in
response to this notice will be treated as
objections to the grant of the
contemplated license. Only written
comments and/or applications for a
license which are received by CDC
within thirty days of this notice will be
considered. Comments and objections
submitted in response to this notice will
not be made available for public
inspection, and, to the extent permitted
by law, will not be released under the
Freedom of Information Act, 5 U.S.C.
552. A signed Confidential Disclosure
E:\FR\FM\30AUN1.SGM
30AUN1
]]>Agencies
[Federal Register Volume 71, Number 168 (Wednesday, August 30, 2006)]
[Notices]
[Page 51624]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-14424]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Savannah River Site Dose Reconstruction Project
AGENCY: The Centers for Disease Control and Prevention (CDC) and the
Agency for Toxic Substances and Disease Registry (ATSDR).
ACTION: CDC and ATSDR announce the following meeting.
-----------------------------------------------------------------------
Name: Public Meeting to Present Final Report of the Savannah River
Site Dose Reconstruction Project.
Time and Date: 6 p.m.-8 p.m., (Eastern Time), Tuesday, September
19, 2006.
Place: University of South Carolina/Aiken, Conference Center/
Business and Education Building, Room 122, 471 University Parkway,
Parking Lot ``C'', Aiken, South Carolina 29801.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 50 people.
Background: Under a Memorandum of Understanding (MOU) signed in
December 1990 with DOE, and replaced by MOUs signed in 1996 and 2000,
the Department of Health and Human Services (HHS) was given the
responsibility and resources for conducting analytic epidemiologic
investigations of residents of communities in the vicinity of DOE
facilities, workers at DOE facilities, and other persons potentially
exposed to radiation or to potential hazards from non-nuclear energy
production use. HHS delegated program responsibility to CDC.
In addition, a memo was signed in October 1990 and renewed in
November 1992, 1996, and in 2000, between ATSDR and DOE. The MOU
delineates the responsibilities and procedures for ATSDR's public
health activities at DOE sites required under sections 104, 105, 107,
and 120 of the Comprehensive Environmental Response, Compensation, and
Liability Act (CERCLA or ``Superfund''). These activities include
health consultations and public health assessments at DOE sites listed
on, or proposed for, the Superfund National Priorities List and at
sites that are the subject of petitions from the public; and other
health-related activities such as epidemiologic studies, health
surveillance, exposure and disease registries, health education,
substance-specific applied research, emergency response, and
preparation of toxicological profiles.
Purpose: CDC will present the Final Report of the Savannah River
Site Dose Reconstruction Project to area stakeholders and provide a
forum for community interaction. This meeting will also serve as a
vehicle for members of the public to express concerns to CDC.
Matters To Be Discussed: The National Center for Environmental
Health (NCEH) will make a presentation of the Final Report of the
Savannah River Site Dose Reconstruction Project. There will be time for
public questions and comments. Agenda items are subject to change as
priorities dictate.
Contact Person For Additional Information: Phillip R. Green, Public
Health Advisor, Radiation Studies Branch, Division of Environmental
Hazards and Health Effects, NCEH, CDC, 1600 Clifton Road, NE., (MS-
E39), Atlanta, GA 30333, telephone 404/498-1717, fax 404/498-1811, or
e-mail address: prg1@cdc.gov
Dated: August 23, 2006.
James D. Seligman,
Chief Information Officer, Centers for Disease Control and Prevention
(CDC).
[FR Doc. E6-14424 Filed 8-29-06; 8:45 am]
BILLING CODE 4163-18-P
